US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Cold Relief

Reason cGMP deviations

Ultra Seal Corporation NDC 42961-112-03 D-0483-2022
Class II · Moderate risk Terminated

Backache & Muscle Relief

Reason cGMP deviations

Ultra Seal Corporation NDC 42961-111-83 D-0482-2022
Class II · Moderate risk Terminated

Multi-Symptom Cramp Relief

Reason cGMP deviations

Ultra Seal Corporation D-0481-2022
Class II · Moderate risk Terminated

Multi Symptom Cold Relief

Reason cGMP deviations

Ultra Seal Corporation D-0478-2022
Class II · Moderate risk Terminated

Back Pain-Off

Reason cGMP deviations

Ultra Seal Corporation NDC 47682-073-00 D-0476-2022
Class II · Moderate risk Terminated

MidNite Sleep Health

Reason cGMP deviations

Ultra Seal Corporation D-0475-2022
Class II · Moderate risk Terminated

Dologen

Reason cGMP deviations

Ultra Seal Corporation NDC 52083-482-02 D-0474-2022
Class II · Moderate risk Terminated

Ephedrine Plus

Reason cGMP deviations

Ultra Seal Corporation NDC 65193-320-24 D-0473-2022
Class II · Moderate risk Terminated

Cystex Urinary Pan Relief

Reason cGMP deviations

Ultra Seal Corporation NDC 69693-512-40 D-0471-2022
Class II · Moderate risk Terminated

Extra Strength

Reason cGMP deviations

Ultra Seal Corporation D-0469-2022
Class II · Moderate risk Terminated

Chloresin

Reason cGMP deviations

Ultra Seal Corporation NDC 51532-0107-2 D-0468-2022
Class II · Moderate risk Terminated

AERO TAB Cold Relief

Reason cGMP deviations

Ultra Seal Corporation D-0466-2022
Class II · Moderate risk Terminated

Nasal & Sinus Decongestant

Reason cGMP deviations

Ultra Seal Corporation D-0464-2022
Class II · Moderate risk Terminated

Proctofoam HC

Reason cGMP deficiencies

Mylan Pharmaceuticals Inc NDC 0037-6822-10 D-0452-2022
Class III · Low risk Terminated

Bortezomib

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-865-60 D-0577-2022
Class III · Low risk Terminated

Azacitidine

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-465-62 D-0576-2022
Class III · Low risk Terminated

Azacitidine

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-305-62 D-0575-2022